Buccal Drug Delivery Systems Market Size & Forecast to 2030

The Buccal Drug Delivery Systems Market grew from USD 2.43 billion in 2024 to USD 2.67 billion in 2025. It is expected to continue growing at a CAGR of 9.44%, reaching USD 4.18 billion by 2030.

Setting the Stage for Buccal Therapeutics

Buccal drug delivery has emerged as a compelling alternative to traditional oral and injectable routes, leveraging the unique properties of the oral mucosa to enhance bioavailability and patient compliance. By delivering active pharmaceutical ingredients directly to the highly vascularized buccal tissue, this platform bypasses first-pass hepatic metabolism and mitigates gastrointestinal degradation. These characteristics position buccal formulations as a strategic choice for competitive differentiation in sectors ranging from pain management to hormone therapy.

Recent advancements in polymer science, formulation engineering, and patient-centric design have propelled buccal systems into a phase of rapid innovation. From cellulose derivatives that optimize film dissolution to mucoadhesive gels that sustain drug release, each formulation class underscores the potential to address unmet clinical needs. As chronic diseases and personalized medicine continue to shape healthcare priorities, buccal delivery stands at the forefront of next-generation therapeutics. This executive summary offers a concise yet comprehensive overview of the transformative trends, regulatory shifts, segmentation insights, regional dynamics, and actionable recommendations critical for stakeholders navigating this evolving landscape.

Emerging Forces Redefining Buccal Delivery

Innovation in buccal delivery is no longer confined to incremental tweaks; it is being driven by converging forces that promise to redefine the entire therapeutic paradigm. Advances in mucoadhesive polymer matrices, including natural and synthetic variants, have unlocked new capabilities for controlled release and targeted dosing schedules. Meanwhile, integration with digital health solutions-ranging from sensor-embedded patches to smartphone-enabled adherence tracking-has introduced a level of connectivity that empowers both patients and providers.

Regulatory frameworks are evolving in parallel, with health authorities increasingly receptive to alternative dosage forms that demonstrate clear clinical advantages. Harmonization of guidelines across major markets is accelerating the path from concept to commercialization, although regional nuances in approval processes still require strategic planning. Supply chain innovations, particularly those focused on near-shoring and supplier diversification, are also reshaping production models in response to geopolitical and logistical challenges.

As we move forward, the interplay between formulation science, regulatory evolution, and patient-driven digital platforms will determine which buccal therapies achieve widespread adoption. Stakeholders who anticipate these transformative shifts and position themselves accordingly will harness significant competitive advantage.

Assessing the 2025 U.S. Tariff Disruption

The introduction of new tariffs by the United States in 2025 has exerted tangible pressure on the buccal drug delivery supply chain, particularly regarding key raw materials such as specialized polymers, cellulose derivatives, and critical excipients. Manufacturers now face elevated input costs that erode margin floors and require recalibration of pricing strategies to maintain profitability without sacrificing uptake.

In response, leading organizations are exploring near-shore manufacturing partnerships and forging direct trade agreements to mitigate customs duties. Some have initiated long-term procurement contracts that lock in favorable pricing, while others are accelerating the adoption of alternative polymer sources to diversify risk. These adjustments are accompanied by enhanced collaboration with logistics providers, aiming to streamline customs clearance and reduce dwell times at ports.

While the tariff environment introduces complexity, it also incentivizes process optimization and supplier innovation. By proactively aligning procurement, production, and distribution strategies, stakeholders can absorb cost shocks and preserve the momentum of buccal delivery advancements.

Unveiling Market Segmentation Dynamics

A granular view of product categories reveals that thin films dominate the buccal delivery landscape, owing to their ease of administration and adaptability to a wide range of active molecules. Within this segment, cellulose derivatives serve as the backbone of film integrity, with hydroxypropyl methylcellulose and microcrystalline cellulose leading research efforts. Natural and synthetic polymer blends are also gaining traction, offering tunable dissolution profiles that cater to various therapeutic objectives.

Hydrogel-based gels differentiate themselves by delivering sustained release through a hydrated matrix, while organogels provide enhanced permeability for lipophilic compounds. Patch systems, split between adhesive and matrix designs, address patient comfort and dosage precision. Spray formulations, whether multi-actuation for consistent microdosing or single-actuation for discrete applications, exemplify rapid-onset therapies. Tablets oriented toward buccal adhesion, encompassing chewable, lozenge, and mucoadhesive variants, broaden the route’s applicability to diverse patient populations.

When considering drug classes, analgesic applications leveraging buprenorphine and fentanyl continue to lead, buoyed by demand for noninvasive pain management. Nitroglycerin’s cardiovascular applications underscore the route’s strength in acute interventions, while hormone therapies based on estradiol and testosterone benefit from steady-state delivery without gastrointestinal degradation. The central nervous system segment and emerging psychiatric indications further illustrate the route’s versatility.

In terms of clinical use cases, cardiovascular treatment and hormone therapy capture substantial attention, complemented by robust growth in pain management and nascent promise in psychiatry. Clinics remain the primary point of care, yet home settings increasingly adopt buccal solutions for chronic therapy, and hospitals leverage these systems for rapid-response scenarios. Distribution channels span hospital pharmacies, traditional retail outlets, and a rising online pharmacy presence that caters to digitally engaged patients.

Regional Nuances Shaping Buccal Adoption

The Americas continue to spearhead buccal delivery adoption, propelled by substantial R&D investments, supportive reimbursement frameworks, and a mature regulatory environment that prioritizes patient-centric innovations. The region’s ecosystem of clinical trial networks and commercial manufacturing facilities facilitates rapid scale-up once a formulation achieves approval.

Europe, the Middle East & Africa present a diverse mosaic of regulatory nuances and healthcare infrastructures. Western Europe aligns closely with stringent EMA guidelines, fostering advanced formulation approvals, while emerging markets within the region show growing interest but require tailored pricing strategies. Africa’s inclusion in pan-continental harmonization efforts promises to open new corridors for buccal therapies that address both communicable and noncommunicable diseases.

Asia-Pacific represents the fastest-growing adopter of buccal systems, driven by expanding healthcare access, aging populations, and rising demand for noninvasive therapies. Local manufacturers in key markets such as China and India are forging alliances with global innovators to localize production and navigate domestic regulatory pathways. Digital health integration and cost-effective manufacturing further accelerate uptake across this dynamic region.

Competitive Landscape and Strategic Players

The competitive landscape features a blend of pharmaceutical giants and specialized delivery technology firms. Established players such as Johnson & Johnson and Novartis leverage extensive formulation portfolios and global distribution networks to secure leadership in mainstream buccal applications. Generics manufacturers including Teva Pharmaceuticals and Viatris focus on streamlined production and cost management to capture price-sensitive segments.

Meanwhile, niche innovators like 3M Drug Delivery Systems and Aptar Pharma concentrate on proprietary polymer matrices and device integration, collaborating with biotech firms to co-develop targeted therapies. Licensing agreements and strategic partnerships remain central to advancing cutting-edge research into commercial realities. Mergers and acquisitions serve to consolidate capacity and expand geographic reach, especially in emerging markets where local expertise strengthens market entry prospects.

This intricate web of alliances and competitive strategies underscores the importance of agility and technical differentiation in the buccal delivery arena.

Strategic Imperatives for Industry Leadership

Industry leaders should prioritize the development of advanced polymer platforms that offer both adhesion and controlled release, ensuring differentiated clinical benefits. Concurrently, diversifying supply chains through a mix of local and global suppliers will mitigate the impact of tariff fluctuations and logistical disruptions.

Early engagement with regulatory bodies will streamline approval pathways, particularly for novel formulation components and device-enabled therapies. Investments in digital health integration, such as adherence monitoring and patient education tools, can elevate the overall value proposition and strengthen payer negotiations.

Expanding into underserved therapeutic areas like psychiatric indications will unlock new avenues for buccal delivery impact. Collaboration with contract research organizations and academic institutions can accelerate proof-of-concept studies, while strategic alliances with distribution partners-especially in the e-commerce space-can broaden patient reach. By aligning R&D, regulatory strategy, and commercial execution, leaders can secure sustainable growth in the buccal drug segment.

Research Framework Underpinning Insights

This analysis draws upon a hybrid research methodology, combining in-depth interviews with senior executives across pharmaceutical companies, polymer suppliers, and regulatory agencies with a comprehensive review of peer-reviewed literature, patent filings, and clinical trial registries. Quantitative data on formulation approvals, drug pipelines, and distribution channels were synthesized alongside qualitative insights from focus groups and expert roundtables.

Rigorous triangulation protocols ensured consistency across data sources, while a thematic analysis framework identified recurring patterns in innovation adoption, supply chain resilience, and regulatory evolution. Regional case studies provided contextual depth, and scenario planning techniques illuminated potential responses to tariff regimes and market shifts. This robust approach underpins the credibility and relevance of the findings presented herein.

Synthesis of Key Findings

Buccal drug delivery stands poised at a nexus of scientific advancement and practical necessity, offering a versatile route that addresses myriad therapeutic challenges. The convergence of polymer innovation, regulatory openness, and digital integration creates a fertile ground for next-generation formulations. While U.S. tariffs pose temporary headwinds, they also catalyze strategic supply chain and procurement reforms.

Product segmentation underscores the dominance of films and the growing relevance of gels, patches, sprays, and buccal tablets. Drug class analysis highlights pain management and hormone therapy as core drivers, with emerging opportunities in cardiovascular and psychiatric applications. Regional dynamics and competitive positioning reveal a landscape characterized by both collaboration and strategic differentiation.

The actionable recommendations outlined herein provide a roadmap for organizations seeking to lead in this dynamic space, emphasizing polymer R&D, regulatory partnerships, and digital patient engagement.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

Product Type
- Films
  - Cellulose Derivatives
    - Hydroxypropyl Methylcellulose
    - Microcrystalline Cellulose
  - Natural Polymers
  - Synthetic Polymers
- Gels
  - Hydrogels
  - Organogels
- Patches
  - Adhesive Patches
  - Matrix Patches
- Sprays
  - Multi Actuation
  - Single Actuation
- Tablets
  - Chewable Tablets
  - Lozenges
  - Mucoadhesive Tablets
Drug Class
- Analgesics
  - Buprenorphine
  - Fentanyl
- Cardiovascular
  - Nitroglycerin
- Central Nervous System
- Hormones
  - Estradiol
  - Testosterone
Application
- Cardiovascular Treatment
- Hormone Therapy
- Pain Management
- Psychiatry
End User
- Clinics
- Home Care
- Hospitals
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

Americas
- United States
  - California
  - Texas
  - New York
  - Florida
  - Illinois
  - Pennsylvania
  - Ohio
- Canada
- Mexico
- Brazil
- Argentina
Europe, Middle East & Africa
- United Kingdom
- Germany
- France
- Russia
- Italy
- Spain
- United Arab Emirates
- Saudi Arabia
- South Africa
- Denmark
- Netherlands
- Qatar
- Finland
- Sweden
- Nigeria
- Egypt
- Turkey
- Israel
- Norway
- Poland
- Switzerland
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Indonesia
- Thailand
- Philippines
- Malaysia
- Singapore
- Vietnam
- Taiwan

This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:

GlaxoSmithKline plc
Novartis AG
Johnson & Johnson
Pfizer Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Bausch Health Companies Inc.
BioDelivery Sciences International, Inc.
Roche Holding AG

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Buccal Drug Delivery Systems Market, by Product Type

8.1. Introduction
8.2. Films
8.2.1. Cellulose Derivatives
8.2.1.1. Hydroxypropyl Methylcellulose
8.2.1.2. Microcrystalline Cellulose
8.2.2. Natural Polymers
8.2.3. Synthetic Polymers
8.3. Gels
8.3.1. Hydrogels
8.3.2. Organogels
8.4. Patches
8.4.1. Adhesive Patches
8.4.2. Matrix Patches
8.5. Sprays
8.5.1. Multi Actuation
8.5.2. Single Actuation
8.6. Tablets
8.6.1. Chewable Tablets
8.6.2. Lozenges
8.6.3. Mucoadhesive Tablets

9. Buccal Drug Delivery Systems Market, by Drug Class

9.1. Introduction
9.2. Analgesics
9.2.1. Buprenorphine
9.2.2. Fentanyl
9.3. Cardiovascular
9.3.1. Nitroglycerin
9.4. Central Nervous System
9.5. Hormones
9.5.1. Estradiol
9.5.2. Testosterone

10. Buccal Drug Delivery Systems Market, by Application

10.1. Introduction
10.2. Cardiovascular Treatment
10.3. Hormone Therapy
10.4. Pain Management
10.5. Psychiatry

11. Buccal Drug Delivery Systems Market, by End User

11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals

12. Buccal Drug Delivery Systems Market, by Distribution Channel

12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy

13. Americas Buccal Drug Delivery Systems Market

13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina

14. Europe, Middle East & Africa Buccal Drug Delivery Systems Market

14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland

15. Asia-Pacific Buccal Drug Delivery Systems Market

15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan

16. Competitive Landscape

16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Novartis AG
16.3.3. Johnson & Johnson
16.3.4. Pfizer Inc.
16.3.5. Bayer AG
16.3.6. Teva Pharmaceutical Industries Ltd.
16.3.7. Viatris Inc.
16.3.8. Bausch Health Companies Inc.
16.3.9. BioDelivery Sciences International, Inc.
16.3.10. Roche Holding AG

17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix

List of Figures

FIGURE 1. BUCCAL DRUG DELIVERY SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. BUCCAL DRUG DELIVERY SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. BUCCAL DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BUCCAL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BUCCAL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

List of Tables

TABLE 1. BUCCAL DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORGANOGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ADHESIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MULTI ACTUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SINGLE ACTUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MUCOADHESIVE TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NITROGLYCERIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ESTRADIOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 90. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 91. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 92. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 93. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 94. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 95. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 97. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 98. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 99. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 175. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 178. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 179. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 183. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 184. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. GERMANY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 189. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 190. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 191. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 192. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 193. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 194. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 196. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 197. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 198. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 217. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 218. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 219. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 220. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 221. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 222. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 223. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 224. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 225. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 226. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. ITALY BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 231. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 232. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 233. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 234. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 235. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 236. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 237. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 238. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 239. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 240. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SPAIN BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 287. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 288. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 289. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 290. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 291. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 292. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 293. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 294. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 295. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 296. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. DENMARK BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. QATAR BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. QATAR BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2030 (USD MILLION)
TABLE 315. QATAR BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 316. QATAR BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 317. QATAR BUCCAL DRUG DELIVERY

Companies Mentioned

The companies profiled in this Buccal Drug Delivery Systems market report include:

GlaxoSmithKline plc
Novartis AG
Johnson & Johnson
Pfizer Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Bausch Health Companies Inc.
BioDelivery Sciences International, Inc.
Roche Holding AG

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	May 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 2.67 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.18 Billion
Compound Annual Growth Rate	9.4%
Regions Covered	Global
No. of Companies Mentioned	11

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3245EUR$3,545USD£2,721GBP €3606EUR$3,939USD£3,024GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3501EUR$3,824USD£2,935GBP €3890EUR$4,249USD£3,262GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4745EUR$5,183USD£3,979GBP €5272EUR$5,759USD£4,421GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5742EUR$6,272USD£4,815GBP €6379EUR$6,969USD£5,349GBP

Buccal Drug Delivery Systems Market by Product Type, Drug Class, Application, End User, Distribution Channel - Global Forecast to 2030

Setting the Stage for Buccal Therapeutics

Emerging Forces Redefining Buccal Delivery

Assessing the 2025 U.S. Tariff Disruption

Unveiling Market Segmentation Dynamics

Regional Nuances Shaping Buccal Adoption

Competitive Landscape and Strategic Players

Strategic Imperatives for Industry Leadership

Research Framework Underpinning Insights

Synthesis of Key Findings

Market Segmentation & Coverage

Table of Contents

Companies Mentioned

Methodology

Table Information

Setting the Stage for Buccal Therapeutics

Emerging Forces Redefining Buccal Delivery

Assessing the 2025 U.S. Tariff Disruption

Unveiling Market Segmentation Dynamics

Regional Nuances Shaping Buccal Adoption

Competitive Landscape and Strategic Players

Strategic Imperatives for Industry Leadership

Research Framework Underpinning Insights

Synthesis of Key Findings

Market Segmentation & Coverage

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges), By Application (Pain Management, Smoking Cessation, Angina Pectoris), By End-use, By Region, And Segment Forecast, 2024 - 2030

Buccal Drug Delivery Systems Market (2024 Edition): Analysis By Product (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)

Buccal Drug Delivery Systems - Global Strategic Business Report

Buccal Drug Delivery System Market Report 2025

Buccal Drug Delivery System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

About the Buccal Drug Market